Be open about drug failures to speed up research

Be open about drug failures to speed up research

Access to evidence from disappointing drug-development programmes advances the whole scientific process, explain Enrica Alteri and Lorenzo Guizzaro. Access to evidence from disappointing drug-development programmes advances the whole scientific process, explain Enrica Alteri and Lorenzo Guizzaro.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature (London) 2018-11, Vol.563 (7731), p.317-319
Hauptverfasser: Alteri, Enrica, Guizzaro, Lorenzo
Format: Artikel
Sprache:eng
Schlagworte:
631/378/1689/1283
692/308
706/648/697
Alzheimer Disease - drug therapy
Alzheimer's disease
Biomarkers
Clinical trials
Clinical Trials as Topic - methods
Comment
Consortia
Dementia
Drug Development - methods
Drug Industry
Genomics
Humans
Hypotheses
Information Dissemination
Initiatives
Medical research
Medical treatment
Neurodegenerative diseases
Pharmaceutical industry
Proteins
Public domain
R&D
Research & development
Time Factors
Time lag
Treatment Failure
Truth Disclosure
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Access to evidence from disappointing drug-development programmes advances the whole scientific process, explain Enrica Alteri and Lorenzo Guizzaro. Access to evidence from disappointing drug-development programmes advances the whole scientific process, explain Enrica Alteri and Lorenzo Guizzaro.
ISSN:0028-0836
1476-4687
DOI:10.1038/d41586-018-07352-7